IDEV Technologies markets SUPERA, a self-expanding nitinol stent with improved flexibility, radial strength, and kink and crush resistance compared to other stents. SUPERA is approved for use in treating biliary strictures in the US and is being studied for use in the superficial femoral artery. IDEV also develops next-generation medical devices for interventional radiology, vascular surgery, and cardiology, including the SurePath Guidewire and Supera Peripheral Stent System, which are sold worldwide.